PositiveSingles.com - the best, most trusted and largest anonymous STD dating site!
PositiveSingles.com - the best, most trusted and largest anonymous STD dating site!

Google Search

Saturday, December 21, 2013

Herpes viruses associated with cognitive impairment

The herpes virus that produces cold sores during times of stress now has been linked to cognitive impairment throughout life, according to a new University of Michigan study that for the first time shows an impact on children ages 12-16.

Researchers at the U-M School of Public Health study examined the association between two latent herpes viruses—Herpes Simplex Virus Type 1 and cytomegalovirus (CMV)—and cognitive impairment among individuals across three age groups: 6-16, 20-59, and 60 and older. The researchers used data from the National Health and Nutrition Examination Survey.

HSV-1 is the oral herpes virus. Previous research has linked it with neurological disorders associated with aging, including Alzheimer’s disease and dementia, but few studies have examined whether these pathogens may influence cognition beginning early in life.

“This study is a first step in establishing an association between these viruses and cognition across a range of ages in the U.S. population,” said Allison Aiello, associate professor of epidemiology at the U-M School of Public Health.

The research, published in the Journal of Infectious Diseases, demonstrates that HSV-1 is associated with lower reading and spatial reasoning test scores among children ages 12-16; impaired coding speed, which is a measure of visual motor speed and attention, among middle-aged adults; and immediate memory impairment in older adults. CMV also was associated with impairment in coding speed, learning and recall in middle-aged adults.

More than one third of the U.S. population is positive for these viruses by early childhood. Some individuals may not be symptomatic.

“If HSV-1 begins to have impact on cognitive function early in life, HSV-1 infection in childhood may have important consequences for educational attainment and social mobility across the lifespan,” said Amanda Simanek, formerly an assistant research scientist in the U-M Department of Epidemiology and now an assistant professor of epidemiology at the University of Wisconsin-Milwaukee.

“Once acquired, herpes viruses are never cleared from the body and instead persist in a latent state. Such pathogens are, however, subject to reactivation and capable of invading the central nervous system, where they may exert direct damage to brain.”

Simanek said reactivation of herpes viruses triggers the release of pro-inflammatory cytokines, which have been linked to cognitive impairment. Cytokines are hormones involved in cell signaling and regulation; pro-inflammatory cytokines play an important role in the immunological response to infection and tissue injury. Excessive inflammation, however, has been linked to various chronic disease outcomes.

To date, much of the public health focus surrounding herpes viruses has been on treating symptoms and some on prevention.

Herpes viruses associated with cognitive impairment “If future research continues to support this work and identifies a definitive mechanistic pathway, there are several implications for public health preventive measures,” Aiello said. “For example, antivirals targeted against these infections may be recommended as well as continued efforts in developing vaccines to target HSV-1 and CMV.

“These viruses are very ubiquitous and reactivate in response to exposure to stressors. If they are truly detrimental to cognitive function, individuals may want to consider reducing stress to avoid reactivation and possible damage associated with these infections, especially if they are known to be positive for HSV-1 as indicated by the presence of cold sores during times of stress.”

The researchers say further studies are warranted to examine the biological pathways by which these herpes viruses may affect cognitive impairment over time.

Herpes viruses associated with cognitive impairment

View the original article here

Friday, December 20, 2013

Get Rid of Herpes Reviews - Clear Herpes Virus from the Body for a Lifetime

Oakland Gardens, NY -- (SBWIRE) -- 12/12/2013 -- Having the dreadful problem of herpes can be painful, annoying, depressing, and very stressful. Herpes victims are not only subjected to social exclusion but their sexual life is greatly affected as well. Herpes has been the most common sexually transmitted diseases. It can be transmitted very easily through sexual intercourse. People might not even notice the eruption of herpes in their partner until it’s too late. Sarah Wilcox’s eBook - Get Rid of Herpes – is specifically designed to eliminate the root cause of herpes by utilization of efficient methods and techniques to help sufferers of herpes to live a herpes free and healthy lifestyle. Not only this, this eBook reveals methods to heal the blisters and stop further outbreaks of herpes. All in all, Get Rid of Herpes is worth a try as it guarantees victims a herpes free life.

Sarah Wilcox was a former victim of herpes. She has been suffering from herpes throughout the better days of her life but only until recently, she was fortunate to find out this effective herpes treatment. With the help of this remedy, Wilcox had to no longer go through the different courses of anti-viral medications and was blessed to live a herpes free and healthy life once again. A great number of people all around the world suffer from this awful disease and doctors just treat this as a form of an allergy and carry the misconception that it can only be treated temporarily until the anti-viral medication course is in effect. The truth is, these drugs do not help at all and their overdose can lead to very severe consequences multiplying the misery.

The Get Rid of Herpes Program is one of the most comprehensive natural remedies for herpes that a person can get out there. Moreover, there are no lengthy explanations and complicated terms. All the information is packed into a 46-page eBook guide. It gives a detailed description of Herpes so that it will be easier for customers to understand how the remedy will kill viral pathogens associated with this disease. This eBook explains and analyzes how the science based and proven herpes cure method works efficiently to eradicate the Herpes Simplex Virus. The herpes relief remedy is described in an easy and thorough manner. There is absolutely no difficulty in carrying out the protocol illustrated in Get Rid of Herpes. In addition to this, there is a lot more interesting and helpful information regarding herpes and its remedy. This remedy is not the only solution described in the eBook, a very helpful diet program is also mentioned as a cure in one of the chapters named Herpes Diet Simplex. Sarah Wilcox wants to help the sufferers of Herpes Simplex Virus as she already had been through the worst herpes could do to its victims. Along with her, there are thousands of satisfied customers out there who have used the same method of herpes cure to get rid of it permanently.

Click Here For Get Rid Of Herpes Instant Access

Get Rid of Herpes is designed as a digital publication which demonstrates the herpes treatment protocol in a step-wise manner. Here is a food for thought, if people really want this remedy to work against Herpes Simplex Virus, they should not feel reluctant to carry out the step-by-step herpes treatment protocol and must remain persistent to attain genuine and permanent results of ending rashes and blisters which can be seen within days. However, tackling the virus and terminating future outbreak can take at least a month.

Who does not want a life free of Herpes? No matter how dubious this remedy may look, the fact still remains that this is the only solution discovered till now by Sarah Wilcox to the devastating problem of herpes affecting not only her but millions of people around the world. Sarah Wilcox gave it a try and it successfully worked for her. Through Get Rid of Herpes, Sarah Wilcox has guided the readers about the simple method of herpes cure she carried out on herself. Not only simple, another advantage of this remedy is that it is totally home based regardless of how serious is the stage of the Herpes Simplex Virus. This treatment does not require the use of any drugs, supplements, and herbal herpes formulations. Sarah Wilcox has affirmed a permanent relief from all kinds of herpes through this trouble-free and workable remedy.

About getridofherpes.net

This eBook gives a detailed description of Herpes so that it will be easier for customers to understand how the remedy will kill viral pathogens associated with this disease. It explains and analyzes how the science based and proven herpes cure method works efficiently to eradicate the Herpes Simplex Virus. The herpes relief remedy is described in an easy and thorough manner. There is absolutely no difficulty in carrying out the protocol illustrated in Get Rid of Herpes. In addition to this, there is a lot more interesting and helpful information regarding herpes and its remedy. This remedy is not the only solution described in the eBook, a very helpful diet program is also mentioned as a cure in one of the chapters named Herpes Diet Simplex. Sarah Wilcox wants to help the sufferers of Herpes Simplex Virus as she already had been through the worst herpes could do to its victims. Along with her, there are thousands of satisfied customers out there who have used the same method of herpes cure to get rid of it permanently.

Click Here to Download the Get Rid of Herpes Ebook


View the original article here

Thursday, December 19, 2013

Cancer Is My Herpes: Living With Recurrent Disease

Get Healthy Living Newsletters: Subscribe 2013-12-09-1fav_DSC_3118.jpg

About a year ago, I learned about some "worrisome" spots that had shown up on my quarterly CT scan. This was about six months after my last of 24 chemotherapy infusions, and to say I was bummed upon hearing the news would be an understatement. But I slowly wrapped my brain around the notion of a "third option" relating to cancer, the third option being something between permanent remission from cancer... and death.

Now the thought of just "learning to live with" cancer was unappealing then and is unappealing now. Of course, I (and anyone else without a death wish) would prefer to live a long life, free of illness and disease, without the scepter of cancer hanging over my head. But as a couple of wise blokes named Mick Jagger and Keith Richards once wrote, you can't always get what you want.

Over the course of the past year, I and my oncology team have watched and monitored those worrisome nodules, hoping they'd either go away or at least remain unchanged. The nodes were too small and scattered to biopsy; but since cancer rarely remains completely stagnant, the thought was that if they didn't grow, they likely weren't cancer. Unfortunately, they grew. Not at an alarming rate, but slowly and steadily they grew. And just as slowly and steadily, my CA125 (cancer marker) levels crept upward.

My family and I watched and waited, hoping for the best but fearing the worst, until a couple of weeks ago, my oncologist called me in for the hard conversation.

"Given the growth of these nodules over the past several months, and the increase in your CA125 levels, we do believe your cancer has returned."

As difficult as this was to hear, I have to say I wasn't surprised. I had never rested easily with the knowledge of those mysterious nodules inside me, not even for a day. In my heart of hearts, I think I always knew they were dangerous. I'd hoped with every fiber of my being I was wrong, but my gut told me my fears were well placed.

I did, however, question the use of the terminology about my cancer having "returned." Because even though I was told at the end of treatment more than 18 months ago that my scans and blood work showed "no evidence of disease", we've essentially been watching these spots for more than a year. So my cancer hasn't actually returned. The truth is, my cancer likely never left. When I pressed my oncologist about this, she acknowledged that I was correct. The nodes on my CT scan were now simply large enough to see. However, they'd likely been there all along.

Cancer.org published a helpful informational paper about recurrent cancer, describing how sometimes small clusters of cancer cells that could not be seen or found on scans or other tests, grow large enough over time to be detected or cause symptoms. While I'm not yet experiencing symptoms as a result of the nodules in my pelvic region -- they're still too small -- they are definitely now detectible and need to be addressed.

Right now the plan is for me to resume chemotherapy after the first of the year. And this time I'll likely be on some form of chemo drug for the rest of my life or until there's a cure. The thought of this both exhausts and terrifies me. I don't want to die. My daughter just turned two. I want to be around to see her grow up. I want to grow old with my husband. I'm not ready to go anytime soon... not by a long shot. So I'm scared and even a little angry.

Aside from processing these feelings, exploring treatment options and second opinions, and learning to cope with the stress and anxiety that came with this news, I'm also learning to reframe my thinking about cancer as a recurrent disease. I can no longer look myself in the eye and tell myself with 100 percent certainty that "this time" I'm going to beat cancer for good. In actuality, the cancer will likely continue to crop up, just hopefully with longer periods of time with no detectible activity between "episodes."

While I strongly dislike the thought of this, I also have to acknowledge that many people live long lives with recurrent, incurable disease. Those with rheumatoid arthritis, diabetes, COPD, severe asthma and even HIV, all learn to manage their symptoms with medication, diet, exercise and other lifestyle changes and therapies, and deal with flare-ups as necessary when they occur.

I remember when an HIV/AIDS diagnosis was considered a death sentence. And it was. I lost several friends to the disease in the late 1980s and early 1990s, before the advent of the "AIDS cocktail" of antiretroviral therapy. Today HIV/AIDS is manageable, and considered a chronic illness rather than a fatal one. Turns out, many cancers fall into the same category.

I have to wrap my mind around the fact that, unless a cure is discovered in my lifetime, cancer is going to be part of my life for the rest of my life. Cancer is my herpes. Or my diabetes or RA or COPD. It's in me and I am going to have to accept it and learn to manage and dominate it. I want to live a long life, so in my mind, I have no other choice.

Image via Brooke Kelly Photography

Follow Joanna_Montgomery on Twitter: www.twitter.com/hellojomo

Subscribe

View the original article here

Wednesday, December 18, 2013

Agenus genital herpes vaccine succeeds in mid-stage trial

n">(Reuters) - Agenus Inc said a trial of its experimental genital herpes vaccine reduced the rate at which patients released the virus, reducing the likelihood of infecting others, sending its shares up 32 percent in premarket trading.

The 15 percent reduction in the release of the virus by patients receiving the vaccine in a mid-stage trial compared to those on a placebo, who showed no reduction.

The vaccine, HerpV, also reduced the severity of the infection by 34 percent.

The mid-stage trial had 80 patients with a history of 1-9 herpes recurrences within the prior 12 months. Of them, 70 received the vaccine and 10 received placebo, Agenus said in a statement.

HerpV, being developed as an "off-the-shelf" vaccine, contains Agenus's QS-21 Stimulon adjuvant that boosts specific immune responses.

The trial tested the efficacy of the vaccine by measuring the release of the virus by patients 45 days before and after three injections of HerpV. A majority of the patients also received a booster injection, given 6 months after the first vaccination.

Genital herpes, a highly contagious sexually transmitted infection, is usually caused by the herpes simplex virus (HSV). There are two types of HSV and Agenus's vaccine targets HSV type 2, which most often causes genital herpes.

According to the U.S. Centers for Disease Control and Prevention, 776,000 people in the United States get new herpes infections annually and one out of six people aged 14 to 49 years has genital HSV-2 infection.

Agenus said it expected more data in the first half of 2014, showing how the patients fared after the booster shots.

The company's partners are also testing the QS-21 Stimulon adjuvant in combination with other vaccines.

Agenus shares were up at $3.16 in trading before the bell. The stock closed at $2.40 on Wednesday on the Nasdaq.

(Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty and Kirti Pandey)

Photo

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Slideshow 

Photo

Thousands line up to say goodbye to Nelson Mandela, whose body is lying in state in Pretoria.  Slideshow 

Photo

Some misty views of London's famous fog.  Slideshow 


View the original article here

Tuesday, December 17, 2013

Herpes Simplex

Studies show that genital herpes simplex virus is common. In the United States, one out of five of the total adolescent and adult population are infected with herpes simplex virus.

There are two types of herpes simplex viruses (HSV). HSV type 2 is the one that most commonly causes genital herpes. You can get HSV type 2 during sexual contact with someone who has a genital HSV-2 infection. The infection causes painful sores on the genitals in both men and women. HSV type 1 is the herpes virus that is usually responsible for cold sores of the mouth, the so-called "fever blisters." You get HSV-1 by coming into contact with the saliva of an infected person.

However, HSV type 1 can cause genital herpes, usually caused by oral-genital sexual contact with a person who has the oral HSV-1 infection, and HSV type 2 can cause cold sores.

Herpes can be treated but not cured. Symptoms appear briefly and then disappear; the disease lies dormant in nerve cells, but it may be reactivated by stress or illness. It is believed to be more contagious during active periods when blisters are present, however, it can be transmitted person-to-person without active lesions.

Persons taking drugs that suppress the body's immune system (for example, cancer or organ transplant patients) are at a higher risk of contracting herpes because their bodies are in a weakened state. There is also some evidence that links genital herpes with a higher rate of cancer of the cervix in women.

There are some serious complications of herpes simplex:

Eye infections - the herpes virus may infect the eye and lead to a condition called herpes keratitis. The inflammation results in the feeling that there is something in the eye, pain, sensitivity to light and discharge. Drugs are available that prevent severe scarring of the cornea and in eliminating infection.

Infections in babies - a pregnant woman who has genital herpes at the time of delivery can transmit the virus to her baby as it passes through the birth canal and touches the affected area. The baby can die or suffer severe damage, particularly mental retardation. Women who know that they have had genital herpes or think they might have it during pregnancy should tell their physician so preventive measures can be taken.

A Cesarian section is indicated for some patients. It is estimated that only half of all infants delivered through an infected vagina acquire the disease, but the ones that do are at risk for having a severe infection.

The newborn also is infected by exposure to the virus from non-genital lesions. If the mother or a person working in the nursery has active blisters on the lips or hands, the baby can become infected. Family members and friends with active herpes simplex virus should not handle a newborn.

Note: Pregnant women should avoid sexual contact with a partner with active genital herpes, especially in the later stages of pregnancy. The use of condoms can be suggested for those who will not abstain. There is no evidence to suggest that infection of an infant with herpes simplex virus (HSV type I) carries a different risk than infection with genital herpes HSV type II).

Herpes symptoms can vary. Many infected individuals have few, if any, noticeable symptoms. In people who do have symptoms, the symptoms start 2 to 20 days after the person was exposed to someone with HSV infection. Symptoms may last for several weeks.

The first episode of herpes is usually worse than outbreaks that come later. The predominant symptom of herpes is the outbreak of painful, itching blisters filled with fluid on and around the external sexual organs or, for oral herpes, on or very near the lip. Females may have a vaginal discharge. Symptoms vaguely similar to those of flu may accompany these outbreaks, including fever, headache, muscle aches and fatigue. There may be painful urination, and swollen and tender lymph glands in the groin.

Usually the blisters will disappear without treatment in two to 10 days, but the virus will remain in the body, lying dormant among clusters of nerve cells until another outbreak is triggered. Factors that can trigger an outbreak include stress, illness such as a cold, fever, fatigue, sunburn, menstruation or sexual intercourse.

Many patients are able to anticipate an outbreak when they notice a warning sign (a tingling sensation, called a prodrome) of the approaching illness. It is when they feel signs that an outbreak is about to start that they are particularly contagious, even though the skin still appears normal

Most people with genital herpes have five to eight outbreaks per year, but not everyone has recurrent symptoms. As time goes on, the number of outbreaks usually decreases. Oral herpes can recur as often as monthly or only one or two times each year.

Sores typically come back near the site of the first infection. Usually, as the outbreaks recur, there are fewer sores and they heal faster and are less painful.

Unlike other sexually transmitted diseases, herpes cannot be cured because medication that will attack the virus while it lies dormant in the nerve cells will also damage the nerve cells. However, there is treatment available for acute outbreaks that involves the use of anti-viral drugs such as Acyclovir, Valaclovir or Famcyclovir.

Acyclovir has been found to reduce the reproduction of the virus in initial outbreaks, thus possibly lessening the number of subsequent outbreaks. To be effective, therapy must be started immediately after the first sores appear. Every sexual partner of the infected person needs to be examined, and if necessary, treated.

Famcyclovir has similar effects and may work to prevent a herpes infection from establishing itself if taken soon enough in the course of the illness. Valaclovir has similar effects.

Long-term drug therapy ('suppressive treatment') may be helpful for individuals who suffer frequent recurrent outbreaks. Suppressive treatment will reduce outbreaks by 85 percent and reduces viral shedding by more than 90 percent.

Topical antibiotic ointments also may be applied to prevent secondary bacterial infections.

During an outbreak of genital herpes, a number of measures can be taken to make the patient more comfortable:

Wear loose clothingAvoid excessive heat or sunlightKeep the sore area clean and dryPlace cool or lukewarm cloths on the sore area for short periods of timeDo not use perfumed soaps, sprays, feminine deodorants, or douchesTake aspirin, acetaminophen or ibuprofen for the painAvoid touching soresWash hands if you do touch the sores

What type of treatment will you recommend to decrease the symptoms or the length of the active period?

Will you be prescribing any medication? What are the side effects?

Can laser therapy be used?

How is laser therapy performed?

How effective is this therapy?

Because the chances of contracting this disease increase with the number of sexual partners a person has, limiting the number of partners is the first step toward prevention.

To keep herpes from spreading, intimate contact should be avoided when sores are on the body. Itching, burning or tingling may occur just before the sores develop. Sexual intercourse should be avoided during this time.

Herpes can even be spread when there are no sores or symptoms. To minimize the risk of spreading herpes, latex condoms should be used during all sexual contact. Spermicidal foams and jellies may offer added protection although the evidence on this is controversial.

The herpes virus can also be spread by touching the sores and then touching another part of the body. If you touch the sores, wash your hands with soap and water as soon as possible. Also, do not share towels or clothing with anyone.

Babies can be infected with the herpes virus. If pregnant, you should tell your doctor if you have ever been exposed to anyone with herpes, even if you have never had any symptoms. Your doctor can take special precautions at the time of delivery to protect the baby from getting infected with herpes.

//'); } //]]> //'); //]]> //

View the original article here

Monday, December 16, 2013

HerpV: Genital Herpes Vaccine Shows Promise


Nov 7 (Reuters) - Agenus Inc said a trial of its experimental genital herpes vaccine reduced the rate at which patients released the virus, reducing the likelihood of infecting others, sending its shares up 32 percent in premarket trading.

The 15 percent reduction in the release of the virus by patients receiving the vaccine in a mid-stage trial compared to those on a placebo, who showed no reduction.

The vaccine, HerpV, also reduced the severity of the infection by 34 percent.

The mid-stage trial had 80 patients with a history of 1-9 herpes recurrences within the prior 12 months. Of them, 70 received the vaccine and 10 received placebo, Agenus said in a statement.

HerpV, being developed as an "off-the-shelf" vaccine, contains Agenus's QS-21 Stimulon adjuvant that boosts specific immune responses.

The trial tested the efficacy of the vaccine by measuring the release of the virus by patients 45 days before and after three injections of HerpV. A majority of the patients also received a booster injection, given 6 months after the first vaccination.

Genital herpes, a highly contagious sexually transmitted infection, is usually caused by the herpes simplex virus (HSV). There are two types of HSV and Agenus's vaccine targets HSV type 2, which most often causes genital herpes.

According to the U.S. Centers for Disease Control and Prevention, 776,000 people in the United States get new herpes infections annually and one out of six people aged 14 to 49 years has genital HSV-2 infection.

Agenus said it expected more data in the first half of 2014, showing how the patients fared after the booster shots.

The company's partners are also testing the QS-21 Stimulon adjuvant in combination with other vaccines.

Agenus shares were up at $3.16 in trading before the bell. The stock closed at $2.40 on Wednesday on the Nasdaq. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty and Kirti Pandey)


View the original article here

Sunday, December 15, 2013

When will we see a herpes cure?

home RSS As a feature of CNNhealth.com, our team of expert doctors will answer readers' questions. Here's a question for Dr. Gupta.

From Lloyd Bartley, Bowling Green, Kentucky

“How close are scientists to developing a cure for herpes, figuratively speaking will we be seeing a break through in 10, 20, or even 30 years?”

Answer:

Well, Lloyd, there is good news and bad news on the herpes front. The good news: Researchers have made serious strides and now better understand the mechanism behind herpes outbreaks. The bad news: There is very little funding for that research.

After receiving your question we reached out to a leading herpes expert, Bryan Cullen, the director at the Center for Virology at Duke University. Cullen is hopeful that a cure for herpes could come within 10 years, once funding hurdles are crossed.

Nearly one in five people over age 12 in the U.S. is affected by herpes. It is caused by a virus - either the herpes simplex virus type 1 (HSV-1) or the herpes simplex virus type 2 (HSV-2). Both strains can cause genital herpes, but HSV-1 usually infects the mouth and produces cold sores.

Despite funding challenges, Cullen and his team are inching closer to a cure. They conducted a study recently that identified the pathway herpes takes as it infects. They now know how herpes embeds itself into the cells and how it eludes treatment. Now that they have honed in on the physiology of the disease - and its triggers - researchers believe they are steps closer to creating drugs that could cure herpes.

While we wait for a cure, there are drugs out there that can at least suppress herpes. Three antiviral drugs: acyclovir, valacyclovir, and famciclovir are commonly recommended to quell outbreaks. A physician might recommend taking these drugs when an outbreak occurs to quiet symptoms; or taking them continuously to reduce the likelihood of an outbreak.

And of course the best way to avoid spreading herpes is to abstain from sex, but if you are sexually active, engage in safe-sex practices such as using condoms.

Editor's Note: Medical news is a popular but sensitive subject rooted in science. We receive many comments on this blog each day; not all are posted. Our hope is that much will be learned from the sharing of useful information and personal experiences based on the medical and health topics of the blog. We encourage you to focus your comments on those medical and health topics and we appreciate your input. Thank you for your participation.

(function ($j, win, doc, undef) {'use strict';/**> Set video_embed_count **/if (win.cnn_metadata === undef) {win.cnn_metadata = {};}$j.extend(true, win.cnn_metadata, {"business":{"cnn":{"page":{"video_embed_count":0}}}});}(jQuery, window, document, undefined));

View the original article here